Total lot release volume of HPV vaccines in China 2017-2022

Published by
Wenyi Zhang,
Nov 27, 2023
The number of HPV vaccines released in China increased significantly since 2017. In 2022, the total release volume of HPV vaccines surpassed 62 million doses in the country, reflecting a rise of almost 100 percent from the previous year. The non-infectious recombinant vaccine - 9-valent HPV vaccine - has been ahead of bivalent HPV vaccines in terms of market supply.

Lot release volume of HPV vaccines in China from 2017 to 2022 (in million doses)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

November 2023

Region

China

Survey time period

2017 to 2022

Supplementary notes

* The 2022 figure includes approx. 28 million doses of Cecolin, the HPV vaccine developed by Wantai BioPharm. The figure is not exact, as published by the company.
Figures have been rounded for a better understanding.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccine industry in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccine industry in China

Background

6

Market overview

6

Class I vaccines

6

Class II vaccines

6

International trade

6

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

Vaccine industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in ChinaInsurance industry in ChinaAging population in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.